Next Article in Journal
Ability of Non-Hosts and Cucurbitaceous Weeds to Transmit Cucumber Green Mottle Mosaic Virus
Previous Article in Journal
Hop Latent Viroid: A Hidden Threat to the Cannabis Industry
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 15
Issue 3
10.3390/v15030682
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Effects of Essential Oils and Hydrolates on the Infectivity of Murine Norovirus

by
Loredana Cozzi
1,
Teresa Vicenza
1,
Roberta Battistini
2,*,
Chiara Masotti
2,
Elisabetta Suffredini
1,
Simona Di Pasquale
1,
Marie-Laure Fauconnier
3,
Carlo Ercolini
2 and
Laura Serracca
2
1
Department of Food Safety, Nutrition and Veterinary Public Health, Istituto Superiore di Sanità, 00161 Rome, Italy
2
Department of La Spezia, Istituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta, Via degli Stagnoni 96, 19100 La Spezia, Italy
3
Laboratory of Chemistry of Natural Molecules, Gembloux Agro-Bio Tech, University of Liège, Passage des Déportés 2, 5030 Gembloux, Belgium
*
Author to whom correspondence should be addressed.
Viruses 2023, 15(3), 682; https://doi.org/10.3390/v15030682
Submission received: 20 December 2022 / Revised: 28 February 2023 / Accepted: 3 March 2023 / Published: 4 March 2023
(This article belongs to the Section Viral Immunology, Vaccines, and Antivirals)
Versions Notes

Abstract

:
The use of natural substances with antiviral properties might reduce foodborne viral diseases. In this study, we evaluated the virucidal effect of Citrus limon and Thymus serpyllum essential oils (EOs) and of Citrus Limon, Thymus serpyllum and Thymus vulgaris hydrolates on murine norovirus (MNV), a human norovirus surrogate. To assess the virucidal effect of these natural substances, the reduction in viral infectivity was estimated by comparing the TCID50/mL of untreated viral suspension and the viral suspension treated with hydrolates and EOs at different concentrations. The results showed a natural loss of infectivity of the untreated virus after 24 h of approx. 1 log. The EO (1%) of T. serpyllum, and hydrolates (1% and 2%) of T. serpyllum and T. vulgaris immediately caused a reduction in MNV infectivity of about 2 log but did not provide a further significant decrease after 24 h. Instead, the EO (1%) and hydrolate (1% and 2%) of C. limon exerted an immediate reduction in the viral infectivity of about 1.3 log and 1 log, respectively, followed by a further reduction in infectivity of 1 log after 24 h for the hydrolate. These results will allow for the implementation of a depuration treatment based on the use of these natural compounds.

1. Introduction

Essential oils (EOs) and hydrolates are natural products of plants that can be extracted from the leaves, petals, stems, seeds or roots of plants through hydro-distillation or steam distillation [1]. EOs are the principal products obtained during this process; they are a complex mixture of many different lipophilic, low molecular, aromatic, highly volatile substances which belong to several different chemical classes, including alcohols, ethers, aldehydes, ketones, esters, amines, amides, phenols, heterocycles, and terpenes [1,2]. Hydrolates are a mixture containing a variable quantity of EO (usually less than 1 g/L) and volatile, water-soluble, secondary metabolites [3]. The aromatic profile of hydrosols can significantly differ from the respective EOs because of their lack of hydrophobic, water-insoluble isoprenoid compounds (hydrocarbons) [4]. In the past, hydrosols have been defined as waste products of steam distillation. Recently, many researchers have reconsidered them, analyzing their antimicrobial antifungal and antioxidant capacity [5]. EOs are widely reported as possessing antimicrobial, antimycotic, antiparasitic and insecticidal properties against human pathogens [6,7,8,9,10,11]. The antiviral efficacy of EOs has also been evaluated [12]. In recent years, EOs have more often been investigated against enveloped viruses [13,14,15], while to date, only limited research has looked at the efficacy of EOs against non-enveloped viruses [16,17,18]. While the scientific literature on essential oils is relatively abundant, much less is known about hydrosols [3] and to date, the antiviral effect of hydrosols against human enteric viruses has scarcely been studied [19]. Enteric viruses have been recognized as an important cause of foodborne disease in developed countries. Noroviruses (NoV) have been one of the major responsible agents of viral gastroenteritis worldwide and the main cause of foodborne illness in Europe and US associated with the consumption of oysters [20]. Shellfish depuration as currently applied is not effective for reducing NoV. It is therefore important to identify different post-harvest intervention strategies to reduce this pathogen in oysters and to increase the safety of this food.
NoV is a small (30–35 nm) non-segmented and non-enveloped RNA virus belonging to the Caliciviridae family [20]. NoV does not multiply in vitro in cell cultures; consequently, in laboratory tests, the evaluation of the inactivation efficiency of NoV through any substance or treatments continues to rely largely on the use of easily cultured surrogates with relatively close structural and genetic similarities to NoV, such as feline calicivirus (FCV), murine norovirus (MNV) and Tulane virus (TV) [21,22,23,24]. MNV is considered as the best surrogate for human NoV as it is transmitted via the fecal-oral route, and it can mimic the survival and inactivation of NoV [25]. EOs and hydrolates might offer the possibility of preventing and controlling foodborne diseases and it is worth evaluating their use as a possible additive during the purification treatment of shellfish.
Thymus and Citrus species plants constitute two of the main sources of essential oil, which are extensively studied for their potential uses in the food industry [26,27]. Thymus vulgaris L. and Thymus serpyllum L. or wild thyme of the family Lamiaceae are aromatic flowering plants originating from the Mediterranean region which contain high amounts of EOs rich in polyphenolic compounds—phenolic acids or flavonoids [28,29]. T. serpyllum and T. vulgaris extracts possess antibacterial, antimicrobial, antifungal, and insecticidal effects [30,31,32,33]. T. serpyllum EO also has an inhibitory effect against biofilm-forming microorganisms, but less is known regarding its antiviral properties [34,35]. Regarding hydrosols, only the antiviral activity of Thymus vulgaris against porcine reproductive and respiratory syndrome virus (PRRS) was indicated [36]. Citrus limon (L.) Osbeck (Lemon) is among the most important species of genus Citrus belonging to the Rutaceae family, which includes about 140 genera and 1300 species [37]. Essential oils were composed of 85–99% of volatile components, including monoterpene (limonene), sesquiterpenes, and hydrocarbons; their oxygenated products include aldehydes (citral), ketones, acids, alcohols (linalool), and esters [38]. Limonene (1-methyl-4-(1-methylethenyl)), which is the main ingredient of lemon essential oil, is one of the most common terpenes in nature and is widely found in the volatile oils of various plants [39]. Limonene has broad application prospects in antibacterial and food preservation due to its broad-spectrum bactericidal activity, safety, and low toxicity [40]. Limonene d-limonene and lemon essential oil were found to have antimicrobial activities against foodborne bacterial and fungal pathogens [41,42,43,44]. However, few studies have investigated the antiviral properties of limonene and lemon essential oil [14,18,45,46].
In this study we investigated in vitro the virucidal efficacy of Thymus serpyllum, Thymus vulgaris and Citrus limon hydrolates and Thymus serpyllum and Citrus limon EOs against murine norovirus. The results obtained will be used to implement a depuration treatment of shellfish based on the use of these natural compounds.

2. Materials and Methods

2.1. Virus Strain and Cell Line

The MNV-1 strain was replicated in RAW 264.7 cells, cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 1% glutamine, 1% non-essential amino acids and 2% fetal bovine serum (FBS) incubated in 5% CO2 at 37 °C. EuroClone (Milan, Italy) provided all cell culture media. The viral suspension was prepared via freeze and thaw lysis (1 cycle) of infected monolayers, clarified using low speed centrifugation (800× g) to remove residual debris, and then divided in aliquots and stored at −80 °C until use. The obtained viral stock suspension had a final concentration of 5.4 ± 0.1 log TCID50/mL, calculated by determining the 50% tissue culture infectious dose using the Reed and Muench method [47] using tenfold serial dilutions in 24-well plates.

2.2. Hydrolates and Essential Oils (EOs)

Commercially available essential oils from Citrus limon, Thymus serpyllum (Flora Srl, Pisa, Italy) and hydrolates from Citrus limon, Thymus serpyllum and Thymus vulgaris (I Segreti delle Erbe, Netro, Bl, Italy) were used in this study.
The composition of the EOs were analyzed through gas chromatography/mass spectrometry (GC-MS) using an Agilent GC system 7890B (Agilent, Santa Clara, CA, USA) fitted with a split-splitless injector and coupled to an Agilent MSD 5977B detector. The EOs were diluted in analysis grade hexane (10 µL /10 mL) and one microliter of EOs solution was injected. The analytical conditions were fixed as follows: injection mode: splitless at 280 °C; HP-5MS capillary column (Agilent, Santa Clara, CA, USA) (30 m × 0.25 mm, df = 0.25 µm); temperature program: from 40 °C (2 min) to 300 °C (5 min) at a rate of 6 °C/min. The carrier gas was helium at a flow rate of 1.2 mL/min. The mass spectra were recorded in electron ionization mode at 70 eV (scanned mass range: 35–400 m/z). The source and quadrupole temperatures were fixed at 230 °C and 150 °C, respectively. The identification was performed on the basis of chromatographic retention indices (RI) and through comparison of the recorded spectra with a computed data library (Pal 600K®). Experimental retention index (RI) of the compounds were calculated following the injection of a mixture of n-alkanes C8-C20 (Sigma Aldrich, Darmstadt, Germany). Results were reported as a percentage of the total chromatographic area.
Hydrolates were analyzed via SPME-GC-MS using a 50/30 µm DVB/CAR/PDMS (Supelco, Bellefonte, PA, USA) fiber that was preconditioned according to the instructions of the manufacturer. Extraction was performed for 1 min at 30 °C and the injection was realized at 280 °C, while the chromatographic conditions were the same as for essential oils.

2.3. Cytotoxicity Determination of Hydrolates and EOs on Cells

Preliminary tests were performed on cell cultures to identify the EO and hydrolate concentrations that did not produce a cytotoxic effect. Hydrolate solutions were prepared in serum-free DMEM, while EOs, due to their hydrophobicity, were emulsified in 33% sunflower oil, 0.1% tween 80 physiological saline solution. Solutions of the natural compounds at different concentrations (0.0125%, 0.025%, 0.05%, 0.25%, 0.5%, 1%, 2% v/v) were treated overnight at 4 °C with antibiotic/antimycotic solution (Euroclone) and 1 mL of each concentration was assayed on 24–48 h cell monolayers in a 25 cm2 flask. The monolayers were incubated for 1 h in 5% CO2 at 37 °C. Thereafter, cells were washed twice with Dulbecco’s phosphate buffer solution (DPBS, EuroClone) and maintained with DMEM supplemented with 2% of FBS for 4 days in 5% CO2 at 37 °C. A cytotoxicity effect was qualitatively determined via visual inspection under optical invertoscope. No morphological changes of monolayer, such as lyses, granulation, condensation, vacuolization in the cytoplasm, darkening of cell boundaries and cell detachment, were to be shown.

2.4. Virucidal Effect of Hydrolates and EOs

The highest EO concentration (1% v/v) and hydrolate concentrations (2% v/v) that did not exert a cytotoxic effect were used to treat the MNV-1 suspension to evaluate the virucidal effect. Furthermore, to assess if lower concentrations allowed comparable or proportionate reductions in viral infectivity, EOs and hydrolates were also tested using 0.5% and 1% v/v concentrations, respectively. In detail, virus aliquots (titre of 5.4 ± 0.1 log TCID50/mL) were treated and analyzed immediately (t = 0) and after 24 h (t = 24) of incubation at 20 ± 2 °C [48] with each of the EOs or hydrolates. Untreated viral suspensions, incubated for the same time and at the same temperature, were used as positive controls, while hydrolates solutions and EOs emulsions were used as negative controls. Each treatment condition was assayed in triplicate. Viral titrations were performed by determining the TCID50/mL. Briefly, 100 µL of serial tenfold dilutions of each sample was assayed in 24-well tissue culture plates containing 24–48 h monolayers of RAW cells, and incubated for 1 h in 5% CO2 at 37 °C. After that, the wells were washed twice with 200 µL of PBS and 500 µL of DMEM, supplemented with 2% of FBS, were added to each well; incubation was carried out for up to 6 days in 5% CO2 at 37 °C with daily visual inspection. The reduction in viral infectivity was estimated as log reduction value (LRV) by calculating the log10 N0/ N1, where N0 is the titre for untreated viral suspension and N1 is the titre for treated viral suspension.

2.5. Statistical Analysis

For each treatment, the average and standard deviation of the triplicate analysis were calculated. The statistical significance of differences between treated and untreated samples was determined through one-way analysis of variance (ANOVA) with Bonferroni post hoc comparisons, with a significance level of p < 0.05 (GraphPad Prism v9.5.0, software San Diego, CA, USA).

3. Results

3.1. Chemical Composition of the Hydrolates and EOs

Table 1, Table 2 and Table 3 reports the percentage of each component of the EOs and hydrolates, identified using GC/MS and SPME-GC-MS analysis. In T. serpyllum EO, a total of 31 compounds were identified, while 10 were found in T. serpyllum hydrolate. The two main compounds identified were carvacrol and linalool with respective percentages of 53.96% and 11.88% in EO and 58.67% and 17.11% in the hydrolate. In EO, thymol (5.74%) and terpinene (4.42%) were also abundant compounds, while cymene (11.23%) and terpinene (6.04%) were abundant in the hydrolate (Table 1). In T. vulgaris hydrolate, 12 compounds were identified, with thymol (84.01%) and carvacrol (7.55%) being the most abundant ones. In Citrus limon, the EO and the hydrolate were, respectively, composed of 25 and 12 identified compounds, with the main compounds being very similar: limonene (53.37–53.45%), beta-pinene (18.09–20.60%) and gamma-terpinene (12.55–14.03%) (Table 3).

3.2. Virucidal Effects of Hydrolates and EOs

The results of the inactivation assays are summarized in Table 4. The untreated MNV-1 viral stock (titre of 5.4 ± 0.1 log TCID50/mL) displayed a natural decay of infectivity during the 24 h incubation at 20 ± 2 °C, with a reduction in the infectious titre of 1.2 log TCID50/mL. The MNV-1 aliquot treated with 1% Citrus limon hydrolate solution showed an immediate reduction (t = 0) in MNV-1 infectivity of 0.9 log TCID50/mL; the same reduction of 0.9 log TCID50/ml was observed after 24 h. A similar decrease was also obtained with 2% Citrus limon hydrolate (1.1 log TCID50/mL inactivation immediately and a reduction of 1.1 log after 24 h). Conversely, the treatments with Thymus vulgaris and Thymus serpyllum hydrolates provided the highest instantaneous reduction in viral infectivity: 1.9 and 2.0 log TCID50/mL reduction was achieved with 1% and 2% Thymus vulgaris hydrolate, respectively, while the corresponding Thymus serpyllum concentrations obtained a 2.0 and 1.8 log TCID50/mL reduction in infectious MNV-1. After 24 h of treatment, the obtained viral titres of MNV-1 were almost identical. A comparable behavior was observed in the treatment with EOs. The virus aliquots treated with 1% C. limon showed an immediate reduction (t = 0) of MNV-1 infectivity of about 1.3 log TCID50/mL and a reduction of 0.8 log after 24 h. In contrast, 1% Thymus serpyllum induced a loss of infectivity of 1.9 log TCID50/mL immediately, and the viral titre was unaffected after 24 h of treatment. A lower concentration of both EOs (0.5% v/v) showed no effect either immediately or after 24 h of treatment.

4. Discussion

In this study, we evaluated the in vitro virucidal activity of C. limon, T. serpyllum and T. vulgaris hydrolates and of C. limon and T. serpyllum EOs on non-enveloped human NoV surrogate, MNV-1, to assess their potential use as a depuration treatment in the shellfish industry for the reduction in NoV exposure risks in oysters. For this purpose, we have decided to keep the virus in contact with the EOs and hydrolates for up to 24 h, because this is the time routinely used for the purification of shellfish.
The results obtained clearly showed greater and faster virucidal activity exerted by T. vulgaris and T. serpyllum compared to C. limon. In fact, an immediate reduction of about 2 log was observed after treatment with hydrolates of T. vulgaris and T. serpyllum both 1% and 2% and with T. serpyllum EO at 1%. Instead, the reduction exerted by C. limon hydrolate (both 1% and 2%) and C. limon EO (1%) was of about 1 log both immediately and after 24 h of treatment. Considering the natural decay of MNV-1 infectivity after 24 h at 20 °C, C. limon probably has a lower virucidal efficacy than thyme. In any case, the reduction in the viral infectivity for all the compounds was >90% at t = 0, in detail it was about 99% for the thyme and 92% for the lemon. Moreover, it is important to underline that most of the virucidal effect of these natural compounds is exerted immediately after contact with the virus; thus, longer times do not involve further significant reductions in viral infectivity.
These results refer to the virucidal activity on MNV-1 of the natural compounds tested in this study in the adopted experimental conditions (24 h at 20 °C), considering the possibility of using them in a shellfish purification system. Other authors have conducted similar studies on MNV-1 using essential oils from other plants [49,50]. These authors have shown that the antiviral activity of the EOs is closely linked to the experimental conditions used and to the type of virus.
The antiviral activity of essential oils and hydrolates may be related to the presence of bioactive compounds. T. serpyllum and T. vulgaris contain significant amounts of monoterpenes, such as thymol and carvacrol, while limonene is the ingredient found most commonly in C. limon. From the analysis of the chemical profile of the two hydrolates of thyme used in our study, it is interesting to note that despite the hydrolates having a different concentration of thymol and carvacrol, they presented comparable results for the inactivation of MNV. T. vulgaris hydrosol contains 84% thymol and 7.5% carvacrol, while T. serpyllum hydrosol contains 58% carvacrol and does not contain thymol (Table 1 and Table 2). The chemical composition of hydrosols and EOs varies according to many factors, including seasonal variations, plant maturity and genetics [2]. The chemical diversity of the genus Thymus EO has been reported in several studies showing the existence of different chemotypes on the basis of major oil components [30,51,52]. Thymol and carvacrol are two of the most common chemotypes of the Thymus genus. These compounds are generally considered significant antimicrobial agents due to their richness in phenolic compounds [53]. They showed strong antimicrobial activity against a wide range of microorganisms [54,55,56,57], with a strong synergistic effect when applied together [58]. Carvacrol has been shown to inhibit viruses responsible for food-borne diseases, such as the human rotavirus, or non-enveloped murine norovirus (used as a surrogate of the human norovirus) as well as others, i.e., the human respiratory syncytial virus and acyclovir-resistant herpes simplex virus type 1 [17,59]. However, thymol and carvacrol protect against HIV-target cell fusion [60] but do not show antiviral activity against coxsackievirus B3 [61]; additionally, carvacrol showed low antiviral properties against Phi6 virus, which has been considered a suitable bacteriophage surrogate for coronaviruses.
Gilling et al. [17] determined the antiviral efficacy of carvacrol. Carvacrol was tested at concentrations of 0.25% and 0.5%. Both concentrations resulted in a statistically significant reduction in MNV within 15 min in comparison with the control sample.
Thymol was also effective in reducing the titer of norovirus surrogates in a dose-dependent manner. Thymol at concentrations of 1 and 2% reduced MNV titers by 1.66 and 2.45 log TCID50/mL, respectively [50].
The phytochemical composition of T. serpyllum EO and hydrolate used in this study also showed a high concentration of linalool (11.88% and 17.11%) and cymene (8.3% and 11.23%). Linalool (2,6-dimethyl-2,7-octadien-6-ol) is an aromatic monoterpene alcohol that is widely found in thyme [62]. Several studies have shown an important anticarcinogenic, anti-inflammatory and antibacterial activity [63,64]; however, there are no studies on its possible antiviral activity.
Cymene is considered the most important monoterpene compound occurring in aromatic plants, such as thyme and oregano. This compound shows a variety of biological activities which include antioxidant, antinociceptive, anti-inflammatory, anxiolytic, anticancer and antimicrobial activities [65]. To date, few studies have investigated the antiviral activity of cymene and none against MNV [66,67,68].
Both the EO and the hydrolate of C. limon used in this study contained a high concentration of limonene of about 53%. Limonene is the ingredient found most commonly in both lemon essential oil and hydrosol, and it has antimicrobial and antifungal activity against many foodborne pathogens. However, to date, there are still few studies investigating the antiviral properties of limonene, none of which involve enteric viruses [14,45,46]. In one study, the effect of C. limon at 0.5% against hepatitis A virus (HAV) infectivity showed a statistically significant reduction of 2.84 log TCID50/mL in HAV titer [18]. This is the first study to evaluate the effectiveness of hydrosols of T. serpyllum, T. vulgaris and C. limon against MNV infectivity. To date, only T. vulgaris hydrosol has been evaluated on porcine reproductive and respiratory syndrome virus (PRRS) [36], where the results showed a significative reduction in PRRSV load in vitro (p < 0.05).
There are not many studies investigating how EOs and their active compounds act on viruses; some show they have an action on the viral capsid, but it is difficult to determine whether the reductions in virus infectivity are due to actual damage to the viral particles or to a simple inhibition of virus uptake in host cells. For example, in many cases, viral RNA was not damaged although the virus was no longer infectious [69].
Plant metabolites may exhibit various mechanisms of antiviral activity; they can cause a direct virucidal effect against non-enveloped virus ssRNA by degrading the capsid or viral nucleic acid. Plant-derived compounds can also bind to the surface of the virus without destroying the proteins in the capsid, thus, interfering with its adsorption to host cells [70,71].
In non-enveloped viruses, the capsid protects the integrity of the viral nucleic acid. Viral RNA may remain intact, while changes in the structure of the capsid may deactivate the virus [72,73]. Modification of the virus capsid is one of the mechanisms that can lead to the inhibition of the virus adsorption process, which is associated with its deactivation. In the case of MNV, the results obtained by Gilling et al. [17] indicate that oregano oil containing a high concentration of carvacrol and carvacrol itself affect the complete loss of the integrity of the capsid [17].
Therefore, further studies are needed to understand the molecular mechanism of action of these natural compounds.
Our results show that the EOs and hydrolates of lemon and thyme were able to significantly decrease MNV infectivity during the in vitro experiments within 24 h. Therefore, the use of these substances in the shellfish purification to reduce the risk of exposure to NoV looks promising and worth investigating. Between the EOs and hydrolates, the latter are the most suitable for this purpose as they are easily miscible in water. In vivo application, however, may have many problems to solve, such as the toxicity of hydrosols to oysters and the ability to reduce viral infectivity even when the virus is inside the oyster. It must also be considered that hydrosols have an intense taste and smell, which could modify the taste and aroma of the oysters. Studies will therefore also be needed to evaluate the organoleptic impact of these treatments on mollusks.

5. Conclusions

Among the natural compounds, EOs obtained from plants have more often been investigated for their antimicrobial and antifungal activity. In recent years, antiviral activity has also been studied both with regard to EOs and hydrolates. Even if the hydrolates are the secondary products of the distillation process for the EOs extraction from plants, they maintain those compounds that have antiviral activity. Considering that hydrolates are in an aqueous solution, their use can be advantageous swhere essential oils cannot be used due to their hydrophobicity. The results of this study improve the knowledge about the antiviral activity of EOs and hydrolates and their potential use in food sanitation.

Author Contributions

Conceptualization, L.S., L.C. and E.S.; methodology, L.C., T.V., R.B., C.M. and S.D.P.; formal analysis, L.C., T.V. and E.S.; investigation, L.C., T.V., R.B., C.M. and M.-L.F.; resources, L.C., L.S., E.S., C.E., S.D.P. and M.-L.F.; data curation, L.C., T.V., R.B. and C.M.; writing—original draft preparation, R.B., L.C., T.V. and C.M.; writing—review and editing, R.B., L.C., T.V. and C.M.; supervision, L.S., C.E. and E.S.; project administration, L.S.; funding acquisition, L.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Italian Ministry of Health Grant number IZS PLV 13/19 RC. The APC was funded by IZS PLV 13/19 RC.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

We wish to acknowledge Giuseppina La Rosa of Istituto Superiore di Sanità, Italy, for sharing the culture of MNV-1 and Herbert W. Virgin, Washington University St. Louis, Missouri, United States, for providing the isolated strain to ISS. The authors would also like to thank Franck Michels for his efficient assistance in the analysis of essential oils and hydrolates.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Butnariu, M.; Sarac, I. Essential oils from plants. J. Biotechnol. Biomed. Sci. 2018, 1, 35–43. [Google Scholar] [CrossRef] [Green Version]
  2. Dhifi, W.; Bellili, S.; Jazi, S.; Bahloul, N.; Mnif, W. Essential oils’ chemical characterization and investigation of some biological activities: A critical review. Medicines 2016, 3, 25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. D’Amato, S.; Serio, A.; López, C.C.; Paparella, A. Hydrosols: Biological activity and potential as antimicrobials for food applications. Food Control 2018, 86, 126–137. [Google Scholar] [CrossRef]
  4. Rajeswara Rao, B.R. Hydrosols and water-soluble essential oils: Their medicinal and biological properties. In Recent Progress in Medicinal Plants; Studium Press LLC: Huston, TX, USA, 2013; Volume 36, pp. 119–140. [Google Scholar]
  5. Jakubczyk, K.; Tuchowska, A.; Janda-Milczarek, K. Plant hydrolates—Antioxidant properties, chemical composition and potential applications. Biomed Pharmacother. 2021, 142, 112033. [Google Scholar] [CrossRef] [PubMed]
  6. Bakkali, F.; Averbeck, S.; Averbeck, D.; Idaomar, M. Biological effects of essential oils—A review. Food Chem. Toxicol. 2008, 46, 446–475. [Google Scholar] [CrossRef] [PubMed]
  7. Garzoli, S.; Božović, M.; Baldisserotto, A.; Sabatino, M.; Cesa, S.; Pepi, F.; Vicentini, C.B.; Manfredini, S.; Ragno, R. Essential oil extraction, chemical analysis and anti-Candida activity of Foeniculum vulgare Miller—New approaches. Nat. Prod. Res. 2018, 32, 1254–1259. [Google Scholar] [CrossRef] [PubMed]
  8. Utchariyakiat, I.; Surassmo, S.; Jaturanpinyo, M.; Khuntayaporn, P.; Chomnawang, M.T. Efficacy of cinnamon bark oil and cinnamaldehyde on anti-multidrug resistant Pseudomonas aeruginosa and the synergistic effects in combination with other antimicrobial agents. BMC Complement. Altern. Med. 2016, 16, 158. [Google Scholar] [CrossRef] [Green Version]
  9. Oliveira, T.A.S.; Pagotti, M.C.; Magalhães, L.G.; Crotti, A.E.M. Antischistosomal activity of essential oils: An Updated Review. Chem. Biodivers. 2022, 19, e202100909. [Google Scholar] [CrossRef] [PubMed]
  10. El-Kasem Bosly, H.A. Larvicidal and adulticidal activity of essential oils from plants of the Lamiaceae family against the West Nile virus vector, Culex pipiens (Diptera: Culicidae). Saudi J. Biol. Sci. 2022, 29, 103350. [Google Scholar] [CrossRef]
  11. Kalemba, D.; Kunicka, A. Antibacterial and Antifungal Properties of Essential Oils. Curr. Med. Chem. 2003, 10, 813–829. [Google Scholar] [CrossRef]
  12. Pan, Y.; Deng, Z.; Shahidi, F. Natural bioactive substances for the control of food-borne viruses and contaminants in food. Food Prod. Proc. Nutr. 2020, 2, 27. [Google Scholar] [CrossRef]
  13. Brochot, A.; Guilbot, A.; Haddioui, L.; Roques, C. Antibacterial, antifungal, and antiviral effects of three essential oil blends. Microbiologyopen 2017, 6, 1–6. [Google Scholar] [CrossRef] [PubMed]
  14. Astani, A.; Schnitzler, P. Antiviral activity of monoterpenes beta-pinene and limonene against herpes simplex virus in vitro. Iran, J. Microbiol. 2014, 6, 149–155. [Google Scholar] [PubMed]
  15. Civitelli, L.; Panella, S.; Marcocci, M.E.; de Petris, A.; Garzoli, S.; Pepi, F.; Vavala, E.; Ragno, R.; Nencioni, L.; Palamara, A.T.; et al. In vitro inhibition of herpes simplex virus type 1 replication by Mentha suaveolens essential oil and its main component piperitenone oxide. Phytomedicine 2014, 21, 857–865. [Google Scholar] [CrossRef] [PubMed]
  16. Kim, Y.W.; You, H.J.; Lee, S.; Kim, B.; Kim, D.K.; Choi, J.B.; Kim, J.A.; Lee, H.J.; Joo, I.S.; Lee, J.S.; et al. Inactivation of Norovirus by Lemongrass Essential Oil Using a Norovirus Surrogate System. J. Food Prot. 2017, 80, 1293–1302. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  17. Gilling, D.H.; Kitajima, M.; Torrey, J.R.; Bright, K.R. Antiviral efficacy and mechanisms of action of oregano essential oil and its primary component carvacrol against murine norovirus. J. Appl. Microbiol. 2014, 116, 1149–1163. [Google Scholar] [CrossRef]
  18. Battistini, R.; Rossini, I.; Ercolini, C.; Goria, M.; Callipo, M.R.; Maurella, C.; Pavoni, E.; Serracca, L. Antiviral Activity of Essential Oils Against Hepatitis A Virus in Soft Fruits. Food Environ. Virol. 2019, 11, 90–95. [Google Scholar] [CrossRef] [PubMed]
  19. Hamdi, A.; Halouani, A.; Aouf, I.; Viaene, J.; Marzouk, B.; Kraiem, J.; Jaïdane, H.; Heyden, Y.V. Cytotoxicity and Antiviral Activities of Haplophyllum tuberculatum Essential Oils, Pure Compounds, and Their Combinations against Coxsackievirus B3 and B4. Planta Med. 2021, 87, 827–835. [Google Scholar] [CrossRef] [PubMed]
  20. Ludwig-Begall, L.F.; Mauroy, A.; Thiry, E. Noroviruses-The State of the Art, Nearly Fifty Years after Their Initial Discovery. Viruses 2021, 13, 1541. [Google Scholar] [CrossRef]
  21. Kamarasu, P.; Hsu, H.Y.; Moore, M.D. Research progress in viral inactivation utilizing human norovirus surrogates. Front. Sustain. Food Syst. 2018, 2, 89. [Google Scholar] [CrossRef] [Green Version]
  22. Wobus, C.E.; Thackray, L.B.; Virgin, H.W., 4th. Murine norovirus: A model system to study norovirus biology and pathogenesis. J. Virol. 2006, 80, 5104–5112. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Tree, J.A.; Adams, M.R.; Lees, D.N. Disinfection of feline calicivirus (a surrogate for Norovirus) in wastewaters. J. Appl. Microbiol. 2005, 98, 155–162. [Google Scholar] [CrossRef] [PubMed]
  24. Mohamed, I.M.A.; Jamsransuren, D.; Matsuda, S.; Ogawa, H.; Takeda, Y. Impact of Theaflavins-Enriched Tea Leaf Extract TY-1 against Surrogate Viruses of Human Norovirus: In Vitro Virucidal Study. Pathogens 2022, 11, 533. [Google Scholar] [CrossRef]
  25. Hirneisen, K.A.; Kniel, K.E. Comparing human norovirus surrogates: Murine norovirus and Tulane virus. J Food Prot. 2013, 76, 139–143. [Google Scholar] [CrossRef] [PubMed]
  26. Mustafa, N.E.M. Citrus essential oils: Current and prospective uses in the food industry. Recent Pat. Food Nutr. Agric. 2015, 7, 115–127. [Google Scholar] [CrossRef] [PubMed]
  27. Gutierrez, J.; Barry-Ryan, C.; Bourke, P. Antimicrobial activity of plant essential oils using food model media: Efficacy, synergistic potential and interactions with food components. Food Microbiol. 2009, 26, 142–150. [Google Scholar] [CrossRef] [PubMed]
  28. Stahl Biskup, E.; Sáez, F. Thyme. The Genus Thymus; Medicinal and Aromatic Plants—Industrial Profiles Series; Taylor and Francis: London, UK; New York, NY, USA, 2002. [Google Scholar]
  29. Tardugno, R.; Serio, A.; Purgatorio, C.; Savini, V.; Paparella, A.; Benvenuti, S. Thymus vulgaris L. essential oils from Emilia Romagna Apennines (Italy): Phytochemical composition and antimicrobial activity on food-borne pathogens. Nat. Prod. Res. 2022, 36, 837–842. [Google Scholar] [CrossRef] [PubMed]
  30. Nikolić, M.; Glamočlija, J.; Ferreira, I.C.; Calhelha, R.C.; Fernandes, Â.; Marković, T.; Marković, D.; Giweli, A.; Soković, M.D. Chemical composition, antimicrobial, antioxidant and antitumor activity of Thymus serpyllum L.; Thymus algeriensis Boiss. and Reut and Thymus vulgaris L. essential oils. Ind. Crops Prod. 2014, 52, 183–190. [Google Scholar] [CrossRef]
  31. Ahmad, A.M.; Khokhar, I.; Ahmad, I.; Kashmiri, M.A.; Adnan, A.; Ahmad, M. Study of antimicrobial activity and composition by Gc/ms spectroscopic analysis of the essential oil of Thymus serphyllum. J. Food Saf. 2006, 5, 56–60. [Google Scholar]
  32. Shanaida, M.; Hudz, N.; Białoń, M.; Kryvtsowa, M.; Svydenko, L.; Filipska, A.; Paweł Wieczorek, P. Chromatographic profiles and antimicrobial activity of the essential oils obtained from some species and cultivars of the Mentheae tribe (Lamiaceae). Saudi J. Biol. Sci. 2021, 28, 6145–6152. [Google Scholar] [CrossRef]
  33. Soković, M.D.; Vukojević, J.; Marin, P.D.; Brkić, D.D.; Vajs, V.; van Griensven, L.J. Chemical composition of essential oils of Thymus and Mentha species and their antifungal activities. Molecules 2009, 14, 238. [Google Scholar] [CrossRef] [PubMed]
  34. Čabarkapa, I.; Čolović, R.; Đuragić, O.; Popović, S.; Kokić, B.; Milanov, D.; Pezo, L. Anti-biofilm activities of essential oils rich in carvacrol and thymol against Salmonella Enteritidis. Biofouling 2019, 35, 361–375. [Google Scholar] [CrossRef] [PubMed]
  35. Galovičová, L.; Borotová, P.; Valková, V.; Vukovic, N.L.; Vukic, M.; Terentjeva, M.; Štefániková, J.; Ďúranová, H.; Kowalczewski, P.Ł.; Kačániová, M. Thymus serpyllum Essential Oil and Its Biological Activity as a Modern Food Preserver. Plants 2021, 10, 1416. [Google Scholar] [CrossRef] [PubMed]
  36. Kaewprom, K.; Chen, Y.H.; Lin, C.F. Antiviral activity of Thymus vulgaris and Nepeta cataria hydrosols against porcine reproductive and respiratory syndrome virus. Thai J. Vet. Med. 2017, 47, 25–33. [Google Scholar]
  37. Kamal, G.M.; Anwar, F.; Hussain, A.I.; Sarri, N.; Ashraf, M.Y. Yield and chemical composition of Citrus essential oils as affected by drying pretreatment of peels. Inter. Food Res. J. 2011, 18, 1275–1282. [Google Scholar]
  38. Fisher, K.; Phillips, C. Potential antimicrobial uses of essential oils in food: Is citrus the answer? Trends Food Sci. Technol. 2008, 19, 156–164. [Google Scholar] [CrossRef]
  39. Sun, J.J. D-Limonene: Safety and clinical applications. Altern. Med. Rev. 2007, 12, 259–264. [Google Scholar] [PubMed]
  40. Kim, Y.W.; Kim, M.J.; Chung, B.Y.; Bang du, Y.; Lim, S.K.; Choi, S.M.; Lim, D.S.; Cho, M.C.; Yoon, K.; Kim, H.S.; et al. Safety evaluation and risk assessment of d-Limonene. J. Toxicol. Environ. Health B Crit. Rev. 2013, 16, 17–38. [Google Scholar] [CrossRef] [PubMed]
  41. Han, Y.; Chen, W.; Sun, Z. Antimicrobial activity and mechanism of limonene against Staphylococcus aureus. J. Food Saf. 2021, 41, e12918. [Google Scholar] [CrossRef]
  42. Han, Y.; Sun, Z.; Chen, W. Antimicrobial Susceptibility and Antibacterial Mechanism of Limonene against Listeria monocytogenes. Molecules 2019, 25, 33. [Google Scholar] [CrossRef] [Green Version]
  43. Ben Hsouna, A.; Ben Halima, N.; Smaoui, S.; Hamdi, N. Citrus lemon essential oil: Chemical composition, antioxidant and antimicrobial activities with its preservative effect against Listeria monocytogenes inoculated in minced beef meat. Lipids Health Dis. 2017, 16, 146. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Yu, H.; Lin, Z.X.; Xiang, W.L.; Huang, M.; Tang, J.; Lu, Y.; Zhao, Q.H.; Zhang, Q.; Rao, Y.; Liu, L. Antifungal activity and mechanism of d-limonene against foodborne opportunistic pathogen Candida tropicalis. LWT 2022, 159, 113144. [Google Scholar] [CrossRef]
  45. Gómez, L.A.; Stashenko, E.; Ocazionez, R.E. Comparative study on in vitro activities of citral, limonene and essential oils from Lippia citriodora and L. alba on yellow fever virus. Nat. Prod. Commun. 2013, 8, 249–252. [Google Scholar] [CrossRef] [Green Version]
  46. Fadilah, N.Q.; Jittmittraphap, A.; Leaungwutiwong, P.; Pripdeevech, P.; Dhanushka, D.; Mahidol, C.; Ruchirawat, S.; Kittakoop, P. Virucidal activity of essential oils from Citrus x aurantium L. against influenza A Virus H1N1: Limonene as a potentia l household disinfectant against virus. Nat. Prod. Commun. 2022, 17, 1934578X211072713. [Google Scholar] [CrossRef]
  47. Reed, L.J.; Muench, H. A simple method of estimating fifty per cent endpoint. Am. J. Hyg. 1938, 27, 493–497. [Google Scholar]
  48. Pilotto, M.R.; Souza, D.S.M.; Barardi, C.R.M. Viral uptake and stability in Crassostrea gigas oysters during depuration, storage and steaming. Mar Pollut Bull. 2019, 149, 110524. [Google Scholar] [CrossRef] [PubMed]
  49. Elizaquivel, P.; Azizkhani, M.; Aznar, R.; Sanchez, G. The effect of essential oils on norovirus surrogates. Food Control 2013, 32, 275–278. [Google Scholar] [CrossRef]
  50. Sánchez, G.; Aznar, R. Evaluation of natural compounds of plant origin for inactivation of enteric viruses. Food Environ. Virol. 2015. online ahead of print. [Google Scholar] [CrossRef] [PubMed]
  51. Borugă, O.; Jianu, C.; Mişcă, C.; Goleţ, I.; Gruia, A.T.; Horhat, F.G. Thymus vulgaris essential oil: Chemical composition and antimicrobial activity. J Med Life. 2014, 7, 56–60. [Google Scholar] [PubMed]
  52. Rota, M.; Herrera, A.; Martínez, R.M.; Sotomayor, J.A.; Jordán, M.J. Antimicrobial activity and chemical composition of Thymus vulgaris, Thymus zygis and Thymus hyemalis essential oils. Food Control 2008, 19, 681–687. [Google Scholar] [CrossRef]
  53. Jafri, H.; Ansari, F.A.; Ahmad, I. Prospects of essential oils in controlling pathogenic biofilm. In New Look to Phytomedicine; Khan, M.S.A., Ahmad, I., Chattopadhyay, D., Eds.; Academic Press: Cambridge, MA, USA, 2019; pp. 203–236. [Google Scholar]
  54. Khan, S.T.; Khan, M.; Ahmad, J.; Wahab, R.; Abd-Elkader, O.H.; Musarrat, J.; Alkhathlan, H.Z.; Al-Kedhairy, A.A. Thymol and carvacrol induce autolysis, stress, growth inhibition and reduce the biofilm formation by Streptococcus mutans. AMB Express 2017, 7, 1–11. [Google Scholar] [CrossRef] [Green Version]
  55. Memar, M.Y.; Raei, P.; Alizadeh, N.; Aghdam, M.A.; Kafil, H.S. Carvacrol and thymol: Strong antimicrobial agents against resistant isolates. Rev. Med. Microbiol. 2017, 28, 63–68. [Google Scholar] [CrossRef]
  56. Rúa, J.; Del Valle, P.; de Arriaga, D.; Fernández-Álvarez, L.; García-Armesto, M.R. Combination of carvacrol and thymol: Antimicrobial activity against Staphylococcus aureus and antioxidant activity. Foodborne Pathog. Dis. 2019, 16, 622–629. [Google Scholar] [CrossRef] [PubMed]
  57. Wijesundara, N.M.; Lee, S.F.; Cheng, Z.; Davidson, R.; Rupasinghe, H.V. Carvacrol exhibits rapid bactericidal activity against Streptococcus pyogenes through cell membrane damage. Sci. Rep. 2021, 11, 1–14. [Google Scholar] [CrossRef] [PubMed]
  58. Youssefi, M.R.; Moghaddas, E.; Tabari, M.A.; Moghadamnia, A.A.; Hosseini, S.M.; Farash, B.R.H.; Ebrahimi, M.A.; Mousavi, N.N.; Fata, A.; Maggi, F.; et al. In vitro and in vivo effectiveness of carvacrol, thymol and linalool against Leishmania infantum. Molecules 2019, 24, 2072. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  59. Orhan, I.E.; Özçelik, B.; Kartal, M.; Kan, Y. Antimicrobial and antiviral effects of essential oils from selected Umbelliferae and Labiatae plants and individual essential oil components. Turk. J. Biol. 2012, 36, 239–246. [Google Scholar] [CrossRef]
  60. Mediouni, S.; Jablonski, J.A.; Tsuda, S.; Barsamian, A.; Kessing, C.; Richard, A.; Biswas, A.; Toledo, F.; Andrade, V.M.; Even, Y.; et al. Oregano oil and its principal component, carvacrol, inhibit HIV-1 Fusion into target cells. J. Virol. 2020, 94, e00147-20. [Google Scholar] [CrossRef]
  61. Zeghib, A.; Kabouche, A.; Laggoune, S.; Calliste, C.-A.; Simon, A.; Bressolier, P.; Aouni, M.; Duroux, J.L.; Kabouche, Z. Antibacterial, antiviral, antioxidant and antiproliferative activities of Thymus guyonii essential oil. Nat. Prod. Commun. 2017, 12, 1934578X1701201032. [Google Scholar] [CrossRef] [Green Version]
  62. Schmidt, E.; Wanner, J.; Höferl, M.; Jirovetz, L.; Buchbauer, G.; Gochev, V.; Girova, T.; Stoyanova, A.; Geissler, M. Chemical composition, olfactory analysis and antibacterial activity of Thymus vulgaris chemotypes geraniol, 4-thujanol/terpinen-4-ol, thymol and linalool cultivated in Southern France. Nat. Prod. Commun. 2012, 7, 1934578X1200700833. [Google Scholar] [CrossRef] [Green Version]
  63. Guo, F.; Liang, Q.; Zhang, M.; Chen, W.; Chen, H.; Yun, Y.; Zhong, Q.; Chen, W. Antibacterial activity and mechanism of linalool against Shewanella putrefaciens. Molecules 2021, 26, 245. [Google Scholar] [CrossRef] [PubMed]
  64. Liu, X.; Cai, J.; Chen, H.; Zhong, Q.; Hou, Y.; Chen, W.; Chen, W. Antibacterial activity and mechanism of linalool against Pseudomonas aeruginosa. Microb. Pathog. 2020, 141, 103980. [Google Scholar] [CrossRef] [PubMed]
  65. Marchese, A.; Arciola, C.R.; Barbieri, R.; Silva, A.S.; Nabavi, S.F.; Tsetegho Sokeng, A.J.; Izadi, M.; Jafari, N.J.; Suntar, I.; Daglia, M.; et al. Update on Monoterpenes as Antimicrobial Agents: A Particular Focus on p-Cymene. Materials 2017, 10, 947. [Google Scholar] [CrossRef]
  66. Panagiotopoulos, A.; Tseliou, M.; Karakasiliotis, I.; Kotzampasi, D.M.; Daskalakis, V.; Kesesidis, N.; Notas, G.; Lionis, C.; Kampa, M.; Pirintsos, S.; et al. p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein. Pharmacol. Res. Perspect. 2021, 9, e00798. [Google Scholar] [CrossRef] [PubMed]
  67. Sharifi-Rad, J.; Salehi, B.; Baghalpour, N.; Kobarfard, F.; Sharifi-Rad, M.; Mohammadizade, M. Antiviral activity of monoterpenes thymol, carvacrol and p-cymene against herpes simplex virus in vitro. Int. Pharm. Acta 2018, 1, 73. [Google Scholar] [CrossRef]
  68. Ćavar Zeljković, S.; Schadich, E.; Džubák, P.; Hajdúch, M.; Tarkowski, P. Antiviral Activity of Selected Lamiaceae Essential Oils and Their Monoterpenes Against SARS-Cov-2. Front. Pharmacol. 2022, 13, 893634. [Google Scholar] [CrossRef]
  69. Reichling, J. Antiviral and virucidal properties of essential oils and isolated compounds—A scientific approach. Planta Med. 2022, 88, 587–603. [Google Scholar] [CrossRef] [PubMed]
  70. Gilling, D.H.; Kitajima, M.; Torrey, J.T.; Bright, K.R. Mechanisms of antiviral action of plant antimicrobials against murine norovirus. Appl. Environ. Microbiol. 2014, 80, 4898–4910. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Koch, C.; Reichling, J.; Schneele, J.; Schnitzler, P. Inhibitory effect of essential oils against herpes simplex virus type 2. Phytomedicine 2008, 15, 71–78. [Google Scholar] [CrossRef] [PubMed]
  72. Cliver, D.O. Capsid and infectivity in virus detection. Food Environ. Virol. 2009, 1, 123–128. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Tubiana, T.; Boulard, Y.; Bressanelli, S. Dynamics and asymmetry in the dimer of the norovirus major capsid protein. PLoS ONE 2017, 12, e0182056. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Table
Table 1. Phytochemical composition (%) of essential oil (EO) and hydrolate (H) of Thymus serpyllum (Ts) used in this study, via GC-MS. RI exp: retention index calculated with our experimental results; RI ref: retention index found in the literature for the same compound (source: Pherobase).
Table 1. Phytochemical composition (%) of essential oil (EO) and hydrolate (H) of Thymus serpyllum (Ts) used in this study, via GC-MS. RI exp: retention index calculated with our experimental results; RI ref: retention index found in the literature for the same compound (source: Pherobase).
No. PeakCompound NameRI Exp.RI Ref.EO (Ts)H (Ts)
1Butanoic acid. 2-methyl-. methl ester0.16-
2Beta-thujene9309310.42-
3Alpha-pinene9379391.021.25
4Camphene9529530.240.31
5Beta-pinene9799750.180.26
61-octen-3-ol9829790.32-
7Beta-myrcene9929911.592.02
83-octanol9969930.16-
9Alpha-phellandrene100510050.280.39
103-carene101110110.12-
114-carene101910131.86-
12Cymene102810268.311.23
13Limonene103210310.82-
14Eucalyptol103510350.63-
15Gamma-terpinene106310624.426.04
16Sabinene hydrate107110670.51-
17Terpinolene109010890.39-
18Linalool1103110111.8817.11
19Endo-borneol117111710.89-
20Terpinen-4-ol118111781.41-
21Alpha-terpineol120011890.89-
22D-carvone126312430.19-
23Thymol129412975.74-
24Carvacrol1315131753.9658.67
25Caryophyllene142814181.94-
26Aromandendrene144814390.56-
27Humulene146214550.11-
28Alloaromadendrene150214780.41-
29Delta-cadinene153015240.18-
30Spathulenol158615780.2-
31Caryophyllene oxide159315830.242.73
Table
Table 2. Phytochemical composition (%) of hydrolate (H) of Thymus vulgaris (Tv) used in this study, via GC-MS. RI exp: retention index calculated with our experimental results; RI ref: retention index found in the literature for the same compound (source: Pherobase).
Table 2. Phytochemical composition (%) of hydrolate (H) of Thymus vulgaris (Tv) used in this study, via GC-MS. RI exp: retention index calculated with our experimental results; RI ref: retention index found in the literature for the same compound (source: Pherobase).
No. PeakCompound NameRI Exp.RI Ref.H (Tv)
11-octen-3-ol9519791.71
2Dimethylstyrene106110960.08
3Delta-3-carene107110110.82
4Camphor114411431.54
5Borneol115611652.65
6Gamma-terpinene116810620.85
7Allyltoluene117611510.18
8p-Menth-1-en-8-ol118411890.49
9Thymoquinone125512520.09
10Thymol1287129784.01
11Carvacrol129013177.55
12Alpha-cedrene141013990.02
Table
Table 3. Phytochemical composition (%) of essential oil (EO) and hydrolate (H) of Citrus limon (Cl) used in this study, via GC-MS. RI exp: retention index calculated with our experimental results; RI ref: Retention index found in the literature for the same compound (source: Pherobase).
Table 3. Phytochemical composition (%) of essential oil (EO) and hydrolate (H) of Citrus limon (Cl) used in this study, via GC-MS. RI exp: retention index calculated with our experimental results; RI ref: Retention index found in the literature for the same compound (source: Pherobase).
No. PeakCompound NameRI Exp. RI Ref.EO (Cl)H (Cl)
1Beta-thujene9309310.77-
2Alpha-pinene9379393.313.12
3Camphene9529530.11-
4Beta-pinene98197518.0920.60
5Beta-myrcene9929912.352.72
6Alpha-phellandrene100510050.15-
74-carene101910130.34-
8Cymene102810260.74-
9Limonene1039103153.3753.45
10Beta-ocimene105210500.19-
11Gamma-terpinene1065106212.5514.03
12Terpinolene109010890.670.70
13Linalool110011010.260.30
14Nonanal110511020.11-
15Citronellal115611580.13-
16Terpinen-4-ol118111780.090.10
17Alpha-terpineol119311890.300.35
18Neral124512421.151.28
19Citral127412711.952.24
20(−) -Lavandulyl acetate136612880.85-
21(+) -Lavandulyl acetate138512980.49-
22Caryophyllene142714180.33-
23Alpha-bergamotene144114860.66-
24Valencene149914950.10-
25Beta-bisabolene151215090.941.02
Table
Table 4. In vitro effect of C. limon, T. vulgaris, T. serpyllum hydrolates (H), and of C. limon, T. serpyllum EOs on MNV-1 infectivity immediately after treatment and after 24 h of incubation at 20 ± 2 °C by calculating log reduction value (LRV).
Table 4. In vitro effect of C. limon, T. vulgaris, T. serpyllum hydrolates (H), and of C. limon, T. serpyllum EOs on MNV-1 infectivity immediately after treatment and after 24 h of incubation at 20 ± 2 °C by calculating log reduction value (LRV).
TreatmentViral Titre at t = 0
(log TCDI50/mL ± SD)		LRV Immediately
after Treatment (t = 0)
(log TCDI50/mL ± SD)		Viral Titre at t = 24 h
(log TCDI50/mL ± SD)		LRV
after 24 h of Treatment (log TCDI50/mL ± SD)
Untreated MNV-15.4 ± 0.1-4.2 ± 0.3
H-C. limon 1%4.5 ± 0.20.9 ± 0.33.3 ± 0.30.9 ± 0.6
H-C. limon 2%4.3 ± 0.21.1 ± 0.33.1 ± 0.21.1 ± 0.5
H-T. vulgaris 1%3.5 ± 0.11.9 ± 0.23.5 ± 0.20.7 ± 0.5
H-T. vulgaris 2%3.4 ± 0.12.0 ± 0.23.4 ± 0.10.8 ± 0.4
H-T. serpyllum 1%3.4 ± 0.12.0 ± 0.23.3 ± 0.20.9 ± 0.5
H-T. serpyllum 2%3.6 ± 0.11.8 ± 0.23.2 ± 0.21.0 ± 0.5
EO-C. limon 0.5%5.3 ± 0.30.1 ± 0.44.4 ± 0.10
EO-C. limon 1%4.1 ± 0.21.3 ± 0.33.4 ± 0.10.8 ± 0.4
EO-T. serpyllum 0.5%5.2 ± 0.20.2 ± 0.34.3 ± 0.30
EO-T. serpyllum 1%3.5 ± 0.11.9 ± 0.23.5 ± 0.20.7 ± 0.5
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Cozzi, L.; Vicenza, T.; Battistini, R.; Masotti, C.; Suffredini, E.; Di Pasquale, S.; Fauconnier, M.-L.; Ercolini, C.; Serracca, L. Effects of Essential Oils and Hydrolates on the Infectivity of Murine Norovirus. Viruses 2023, 15, 682. https://doi.org/10.3390/v15030682

AMA Style

Cozzi L, Vicenza T, Battistini R, Masotti C, Suffredini E, Di Pasquale S, Fauconnier M-L, Ercolini C, Serracca L. Effects of Essential Oils and Hydrolates on the Infectivity of Murine Norovirus. Viruses. 2023; 15(3):682. https://doi.org/10.3390/v15030682

Chicago/Turabian Style

Cozzi, Loredana, Teresa Vicenza, Roberta Battistini, Chiara Masotti, Elisabetta Suffredini, Simona Di Pasquale, Marie-Laure Fauconnier, Carlo Ercolini, and Laura Serracca. 2023. "Effects of Essential Oils and Hydrolates on the Infectivity of Murine Norovirus" Viruses 15, no. 3: 682. https://doi.org/10.3390/v15030682

APA Style

Cozzi, L., Vicenza, T., Battistini, R., Masotti, C., Suffredini, E., Di Pasquale, S., Fauconnier, M. -L., Ercolini, C., & Serracca, L. (2023). Effects of Essential Oils and Hydrolates on the Infectivity of Murine Norovirus. Viruses, 15(3), 682. https://doi.org/10.3390/v15030682

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop